Janku Filip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+86,500→ 86,500 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (86,500 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.